Nasopharyngeal Carcinoma Screening
Developing and validating early detection strategies for NPC in high-risk populations using EBV biomarkers and cell-free DNA.
An overview of ongoing and planned research directions in ENT Genomics Lab.
Developing and validating early detection strategies for NPC in high-risk populations using EBV biomarkers and cell-free DNA.
Investigating the tumor immune microenvironment in head and neck cancers, with focus on innate lymphoid cells and immunotherapy approaches.
Innovating diagnostic tools and technologies, including 3D-printed medical devices and digital detection methods for infectious diseases.